Davis's Drug Guide
Overview of Risk Evaluation and Mitigation Systems (REMS)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., et al. "Overview of Risk Evaluation and Mitigation Systems (REMS)." Davis's Drug Guide, 18th ed., F.A. Davis Company, 2023. www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS_.
Vallerand AHA, Sanoski CAC, Quiring CC. Overview of Risk Evaluation and Mitigation Systems (REMS). Davis's Drug Guide. F.A. Davis Company; 2023. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS_. Accessed December 2, 2023.
Vallerand, A. H., Sanoski, C. A., & Quiring, C. (2023). Overview of Risk Evaluation and Mitigation Systems (REMS). In Davis's Drug Guide (18th ed.). F.A. Davis Company. https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS_
Vallerand AHA, Sanoski CAC, Quiring CC. Overview of Risk Evaluation and Mitigation Systems (REMS) [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2023. [cited 2023 December 02]. Available from: https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS_.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Overview of Risk Evaluation and Mitigation Systems (REMS)
ID - 109942
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
AU - Quiring,Courtney,
BT - Davis's Drug Guide
UR - https://www.drugguide.com/ddo/view/Davis-Drug-Guide/109942/all/Overview_of_Risk_Evaluation_and_Mitigation_Systems__REMS_
PB - F.A. Davis Company
ET - 18
DB - Davis's Drug Guide
DP - Unbound Medicine
ER -